Notably, BNP levels were elevated in seropositive compared to seronegative RA patients and were predicted by both baseline and 12-month CRP levels, suggesting that systemic inflammation prior to treatment may shape long-term cardiovascular outcomes. This evidence concerns the gene NPPB and rheumatoid arthritis.